The Altman Lab utilizes transcriptional profiling and multi-omics approaches to understand the molecular mechanisms of disease risk, progression, and response to treatment. The lab collaborates with several large NIH funded consortiums including:
- CAUSE: Childhood Asthma in Urban SEttings
- Formerly ICAC: Inner-City Asthma Consortium
- CHEETAH: MeCHanisms Underlying Asthma Symptoms and Exacerbations Examined Across T2 StAtus in CHildren
- CRITICAL: CockRoach ImmunoTherapy In Children and AdoLescents
- MUPPITS: Mechanisms Underlying asthma exacerbations Prevented and Persistent with Immune-based TherapieS
- PANDA: Prevention of Asthma exacerbatioNs using Dupilumab in urban children and Adolescents
- HIPC: Human Immunology Project Consortium
- IMPACC: IMmuno Phenotyping Assessment in a COVID-19 Cohort
- ITN: Immune Tolerance Network
- CatEEC: Cat dander Environmental Exposure Chamber
- CATNIP: Anti-TSLP + Antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy
- GRASS: Sublingual grass pollen immunotherapy and allergic rhinitis
- MINA: AsthMatic Inflammation and Neurocircuitry Activation
- OPAR: Ohio Pediatric Asthma Repository
- URECA: URban Environment and Childhood Asthma
- CREW: Children’s Respiratory Environmental Workgroup
- CANOE: Childhood Allergy and the NeOnatal Environment
